GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PharMerica Corp (NYSE:PMC) » Definitions » Accounts Receivable

PharMerica (PharMerica) Accounts Receivable : $249 Mil (As of Sep. 2017)


View and export this data going back to 2007. Start your Free Trial

What is PharMerica Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. PharMerica's accounts receivables for the quarter that ended in Sep. 2017 was $249 Mil.

Accounts receivable can be measured by Days Sales Outstanding. PharMerica's Days Sales Outstanding for the quarter that ended in Sep. 2017 was 38.21.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. PharMerica's Net-Net Working Capital per share for the quarter that ended in Sep. 2017 was $-14.22.


PharMerica Accounts Receivable Historical Data

The historical data trend for PharMerica's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharMerica Accounts Receivable Chart

PharMerica Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 205.20 198.60 195.40 200.50 235.40

PharMerica Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.40 235.40 247.80 246.60 249.20

PharMerica Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


PharMerica Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

PharMerica's Days Sales Outstanding for the quarter that ended in Sep. 2017 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=249.2/595.1*91
=38.21

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), PharMerica's accounts receivable are only considered to be worth 75% of book value:

PharMerica's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2017 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(7.8+0.75 * 249.2+0.5 * 139.2-706.8
-0-0)/31.1189
=-14.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


PharMerica Accounts Receivable Related Terms

Thank you for viewing the detailed overview of PharMerica's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PharMerica (PharMerica) Business Description

Traded in Other Exchanges
N/A
Address
PharMerica provides pharmacy services to institutional healthcare providers in the United States. The firm has three operating segments: institutional pharmacy, specialty infusion services, and specialty oncology pharmacy. The institutional pharmacy business provides pharmacy products and services to skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and long-term care settings. It purchases, repackages, and dispenses pharmaceuticals and provides on-call pharmacist services to these customers. The specialty infusions segment delivers specialty infusion therapy to patients outside of hospitals and nursing homes. The specialty oncology pharmacy dispenses oncology drugs and provides care management services to patients, oncology practices, and hospitals.
Executives
Marjorie W Dorr director ANTHEM INC., 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gregory S Weishar director, officer: Chief Executive Officer ONE CVS DR, WOONSOCKET RI 02895
Geoffrey G Meyers director 333 NORTH SUMMIT ST, 16TH FLOOR, TOLEDO OH 43604
Robert E. Dries officer: CFO 701 COOL SPRINGS BOULEVARD FRANKLIN TN 37067
Patrick G Lepore director 17-17 ROUTE 208 N, FAIRLAWN NJ 07410
Thomas A Caneris officer: SVP, GC and Secretary 1901 CAMPUS PLACE, LOUISVILLE KY 40299
Froesel David W Jr officer: Executive VP, CFO & Treasurer
Thomas P Gerrity director
Mac Mahon Thomas P director
Daniel Newman Mendelson director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Edward L Kuntz director
R David Yost director 1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Paul J Diaz director 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202

PharMerica (PharMerica) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012